United States · FDA National Drug Code directory
Aleve
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0280-0113_31bad2d9-c0ba-7f20-e063-6294a90acb17
- Product NDC
- 0280-0113
- Form
- TABLET
- Composition / generic term
- NAPROXEN SODIUM
- Labeler
- Bayer HealthCare LLC.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20230404
- Source listing expiry
- 20261231
Source-listed ingredients
- NAPROXEN SODIUM — 220 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 TABLET in 1 BOTTLE (0280-0113-01) · 0280-0113-01
- 1 BOTTLE in 1 CARTON (0280-0113-02) / 24 TABLET in 1 BOTTLE · 0280-0113-02
- 1 BOTTLE in 1 CARTON (0280-0113-03) / 270 TABLET in 1 BOTTLE · 0280-0113-03
- 1 BOTTLE in 1 CARTON (0280-0113-04) / 50 TABLET in 1 BOTTLE · 0280-0113-04
- 1 BOTTLE in 1 CARTON (0280-0113-05) / 90 TABLET in 1 BOTTLE · 0280-0113-05
- 1 BOTTLE in 1 CARTON (0280-0113-06) / 110 TABLET in 1 BOTTLE · 0280-0113-06
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →